714-1288

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
714 (USA) · Dr. Clarke
consented 2013-12-04

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-03-08 (study day 95.0); relationship: NONE

mild assessed

Mild BACK PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-02-24 (study day 83.0); relationship: NONE

mild assessed

Mild BACK PAIN — outcome: RECOVERED/RESOLVED; onset 2014-02-24 (study day 83.0); relationship: NONE

mild assessed

Mild COUGH — outcome: RECOVERED/RESOLVED; onset 2014-01-22 (study day 50.0); relationship: NONE

mild assessed

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-12-14 (study day 11.0); relationship: POSSIBLE

mild assessed

Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2013-12-13 (study day 10.0); relationship: POSSIBLE

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-11 (study day 39.0); relationship: PROBABLE

mild assessed

Mild NASOPHARYNGITIS — outcome: RECOVERED/RESOLVED; onset 2014-01-22 (study day 50.0); relationship: NONE

moderate assessed

Moderate SINUS BRADYCARDIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-27 (study day 175.0); relationship: REMOTE

Data queries

No data queries.